Jacqueline Mallory Cohen

Epidemiology, pharmacoepidemiology, drug safety, perinatal epidemiology, health registers, treatment of ADHD, epilepsy, mental health conditions

Bio: I am a Senior Researcher in the Department of Chronic Diseases and affiliated member of the Centre for Fertility and Health. I have a PhD in Epidemiology from McGill University and expertise in pharmacoepidemiology and perinatal epidemiology. My main research focus is at the intersection of these fields in studies of medication use and safety in pregnancy. I completed postdoctoral training at Harvard T.H. Chan School of Public Health where my work focused on the safety of psychotropic medication in pregnancy using large U.S. healthcare databases. Since 2018, I have worked on international studies of medication safety in pregnancy based on linked data from nationwide health registers from the five Nordic countries, and administrative data from the US and Australia. I have in-depth knowledge and experience in working with Norwegian health register data, as well as health registers from the other Nordic countries and U.S. insurance claims databases. I led the efforts to harmonize Nordic register data into a Common Data Model for the Nordic Pregnancy drug Safety Studies (NorPreSS) project. I am the PI for a FRIPRO-Young Research Talents grant funded by the Research Council of Norway on potential consequences of use and discontinuation of ADHD medication in pregnancy (8 million NOK, 2020-2025). In this project, data sources include both health registers and the Norwegian Mother, Father and Child Cohort Study (MoBa). User representatives from ADHD Norway who had personal experiences of pregnancy or pregnancy planning with ADHD provided feedback on the project aims and targets for dissemination. I represent Norway on the Executive Committee of the Nordic Pharmaco-Epidemiological Network (NorPEN) and chaired the organizing committee for the annual meeting in 2023.